tm logo
OXCITE
Live/Pending
NON-FINAL ACTION - MAILED

final action

on 18 Dec 2024

Last Applicant/ Owned by

Serial Number

79405679 filed on 19th May 2024

Registration Number

N/A

Correspondent Address

Deborah J. Peckham

Deborah J. Peckham Barclay Damon LLP

Boston, MA 02110

United States

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

OXCITE

Medical and veterinary apparatus and instruments; lasers for use in surgery; lasers for skin treatment. Medical treatment services; health care services for treating alzheimer's disease; providing laser therapy for treating medical conditions; human hygiene and beauty care; hygienic and beauty care for animals.

Classification Information


Class [044]
Medical, Beauty & Agricultural Services


Medical treatment services; health care services for treating alzheimer's disease; providing laser therapy for treating medical conditions; human hygiene and beauty care; hygienic and beauty care for animals.


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [010]
Medical Instrument Products


Medical and veterinary apparatus and instruments; lasers for use in surgery; lasers for skin treatment.


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 79405679

Mark Type

No Service Mark

Attorney Docket Number

No 3220472 WPUS

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
05th Jan 2025REFUSAL PROCESSED BY IB
18th Dec 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
18th Dec 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
18th Dec 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
18th Dec 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
18th Dec 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
18th Dec 2024REFUSAL PROCESSED BY MPU
18th Dec 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06th Dec 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05th Dec 2024NON-FINAL ACTION WRITTEN